NEUROLOGICAL COMPLICATIONS OF MEASLES IN CHILDREN

Authors

  • O. V. Prokopiv Danylo Halytskyi Lviv National Medical University
  • S. A. Lysheniuk Danylo Halytskyi Lviv National Medical University
  • N. M. Prykuda Danylo Halytskyi Lviv National Medical University

DOI:

https://doi.org/10.11603/1681-2727.2019.1.9934

Keywords:

measles, neurological complications, children

Abstract

The aim of the work – to study the clinical course of neurological complications of measles in children, treated at Inpatient Department of Lviv Regional Infectious Clinical Hospital in 2018.

Patients and methods. Monitoring was conducted for 10 children with neurological complications of measles aged from 3 to 16 years. The diagnosis of measles was based on typical clinical manifestations of the disease, data of epidemiological anamnesis, results of general laboratory and immunological investigations.

Results and discussion. In 2018, five children with measles-induced encephalitis were treated at Inpatient Department of Lviv Regional Infectious Clinical Hospital, three – with meningitis and two children with encephalomyelitis. Children aged 3–6 years prevailed. Manifestations of nervous system impairment appeared on the 6–14th day of the disease. A case of measles-induced encephalomyelitis in a vaccinated 16-year-old boy with multiple sclerosis was described.

Conclusions. Among neurological complications, encephalitis dominated, which developed in children with moderate form of measles on the 10–14th day of the disease. Visual hallucinations were a leading initial symptom in all patients. Impairment of the nervous system in the form of encephalomyelitis is a severe complication, characterized by a long-term course. Complete recovery with restoration of impaired functions is possible due to timely intensive treatment. Nowadays, permanent following of a set of listed prophylactic inoculations to prevent measles is crucial, first of all, following vaccination schedules with obligatory anti-epidemic measures in the focus of infection.

Author Biography

O. V. Prokopiv, Danylo Halytskyi Lviv National Medical University

д.мед.н., професор кафедри дитячих інфекційних хвороб ЛНМУ ім. Данила Галицького

References

Timchenko, V.N., Pavlova, E.B., Bulina, O.V., Nazarova, A.N., Leonicheva, O.A., & Timofeeva, E.V. (2015). Kliniko-epidemiologicheskaya evolyutsiya i sovremennaya terapiya kori u detey [Clinical and epidemiological evolution of modern therapy and measles in children]. Zhurnal infektologii – Journal of Infectology, 7 (1), 39-46. Retrieved from: https://doi.org/10.22625/2072-6732-2015-7-1-39-46 [in Russian].

Trykhlib, V.I., Shchur, A.B., Hrushkevych, V.V., Hryshyn, O.S., Pavlovska, M.O., Musiienko, T.I., … Kozachenko L.V. (2018). Osoblyvosti klinichnykh proiaviv ta perebihu koru [Peculiarities of measles clinical manifestations and course]. Aktualna infektolohiia – Actual Infectology, 6 (3), 141-152. DOI:10.22141/2312-413x.6.3.2018.136647 [in Ukrainian].

Filia, A., Bella, A., Del Manso, M., Baggieri, M., Magurano, F., & Rota, M.C. (2017). Ongoing outbreak with well over 4,000 measles cases in Italy from January to end August 2017 − what is making elimination so difficult? Euro Surveill., 22 (37). pii: 30614. doi: 10.2807/1560-7917.ES.2017.22.37.30614.

Surveillance report. (2018). Monthly measles and rubella monitoring report. E-resource. https://ecdc.europa.eu/sites/portal/files/documents/Monthly-Measles-Rubella-monitoring-report-August-2018.pdf.

Ministry of Health of Ukraine (2018). Operatyvni dani zakhvoriuvanosti na kir ta analiz zakhvoriuvanosti za 6 misiatsiv 2018 roku [Operational data on measles and incidence analysis for 6 months of 2018]. E-resource. http://moz.gov.ua/article/news/operativni-dani-zahvorjuvanosti-na-kir-ta-analiz-zahvorjuvanosti-za-6-misjaciv-2018-roku [in Ukrainian].

Shostakovych-Koretska, L.R., Mavrutenkov, V.V., Cherhinets, A.V., Budaieva, I.V., Yakunina, O.M., & Chykarenko, Z.A. (2013). Kir (lektsiia, prodovzhennia) [Measles (lecture, continuing)]. Medychni perspektyvy – Medical Prospects, ХVІII (4), 4-15 [in Ukrainian].

Kopcha, V.S., Ishchuk, I.S., Holyk, Ye.Yu., Nadal, L.S., Herasymenko, O.A., Komar, P.V., & Sapyshchuk, N.O. (2013) Korovyi entsefalit: dyskusii ta rozdumy [Measles encephalitis: discussions and releable]. Infektsiini khvoroby – Infectious Diseases, (2), 88-92 [in Ukrainian]. https://doi.org/10.11603/1681-2727.2012.2.491

Wendorf, K.A., Winter, K., Zipprich, J., Schechter, R., Hacker, J.K., Preas, C., … Harriman, K. (2017). Subacute sclerosing panencephalitis: The devastating measles complication that might be more common than previously estimated. Clin. Infect. Dis., 65 (2):226-232. doi: 10.1093/cid/cix302.

Mandia, D., Ferraro, O.E., Nosari, G., Montomoli, C., Zardini, E., & Bergamaschi, R. (2014). Environmental factors and multiple sclerosis severity: A descriptive study. Int. J. Environ. Res. Public Health., 11 (6), 6417-6432. doi: 10.3390/ijerph110606417.

Angius, F., Smuts, H., Rybkina, K., Stelitano, D., Eley, B., Wilmshurst, J., … Hardie, D. (2018). Analysis of a subacute sclerosing panencephalitis (SSPE) Genotype B3 virus from the 2009/10 South African measles epidemic shows hyperfusogenic F proteins contribute to measles virus infection in the brain. J. Virol. pii: JVI.01700-18. doi: 10.1128/JVI.01700-18.

Nefedov, A.A., & Mamchur, V.I. (2015). Farmakoterapiia rozsiianoho sklerozu – suchasni standarty [Pharmacotherapy of multiple sclerosis – modern standards]. Farmakolohiia ta likarska toksykolohiia – Pharmacology and Doctor’s Toxicology, 3 (44), 10-16 [in Ukrainian].

Balychevtseva, I.V., Gadetskaya, S.G., Bezuglova, I.A., Atroshchenkova, G.A., Storozhenko, L.P., Turpakov, A.V., Kvach, L.E., & Gorbunova, O.V. (2011). Klinicheskiy sluchay sindroma Dendi-Uokera [Clinical case Dandy Walker’s syndrome]. Zdorovye rebenka –Child’s Health, 3 (30), 136-138 [in Russian].

Published

2019-04-02

How to Cite

Prokopiv, O. V., Lysheniuk, S. A., & Prykuda, N. M. (2019). NEUROLOGICAL COMPLICATIONS OF MEASLES IN CHILDREN. Infectious Diseases – Infektsiyni Khvoroby, (1), 14–19. https://doi.org/10.11603/1681-2727.2019.1.9934

Issue

Section

Original investigations